Latest Commercialisation News

Terragen Holdings reports robust quarterly progress, highlighted by successful beef feedlot trials and a $4.76 million equity raise, setting the stage for its new probiotic product launch in March 2025.

HITIQ Limited has extended its Premier League partnership by 18 months with a 60% contract value increase, appointed a new Chief Marketing Officer, and raised an additional $3 million to accelerate global growth.

SportsHero Limited has inked a five-year partnership with Indonesia's Indosat Ooredoo Hutchison to market its Family Game Room product, alongside securing a $1 million debt facility to support its expansion plans.

FBR Limited has successfully completed its US Demonstration Program with CRH Ventures, raising $8 million through a Share Purchase Plan and positioning itself for a significant joint venture in the US construction robotics market.

InteliCare advances its AI-driven platform deployment across multiple Hardi Aged Care sites, while expanding its commercial pipeline and enhancing product capabilities.

ClearVue Technologies has secured key manufacturing and distribution agreements across the Middle East, China, and the UK, while acquiring ROOTS Sustainable Agricultural Technologies to bolster its net zero ag-tech solutions.

Suvo Strategic Minerals delivered a robust December quarter with soaring profits and an extended supply deal, while advancing innovative low carbon cement projects in Australia and Indonesia.

Nanoveu Limited has appointed industry veteran Mark Goranson as CEO of its Semiconductor Technologies division, positioning the company to accelerate growth in ultra-low-power AI-driven chips following its EMASS acquisition.

Atomo Diagnostics reports a robust Q2 FY25 with $1.2 million revenue driven by HIV self-test sales and a significant $2.44 million government grant for syphilis test development. The company advances its market footprint in Australia and New Zealand while maintaining a strong cash position.

Argenica Therapeutics has received a positive safety review from its independent DSMB for the Phase 2 trial of ARG-007 in acute ischaemic stroke patients, with dosing now 86% complete and full recruitment expected by early Q2 2025.

Patagonia Lithium Limited reports a maiden mineral resource estimate of 717,000 tonnes of lithium metal equivalent and advances exploration in Argentina and Brazil, while navigating critical funding negotiations to support its 2025 growth plans.

Mad Paws Holdings Limited reported a milestone positive cash EBITDA of $0.3 million in Q2 FY25, driven by strong marketplace growth and operational efficiencies. The company is amplifying its market presence with a $5.25 million brand campaign in partnership with Seven West Media.